Norway transfers additional vaccine options to COVAX AMC

Norway has contributed to the fight against COVID-19 through the redistribution of future surplus vaccines, by providing financial assistance, and by transferring vaccine options through the COVAX distribution mechanism. 

The transfer of the remaining vaccine options will provide 164,000 Janssen doses and 895,000 Novavax doses to the distribution mechanism, supplying a total of 1.7 million vaccine doses to the COVAX AMC to be distributed among healthcare workers and high-risk groups in low-income countries. 

In addition to transferring vaccine options, Norway is also contributing with NOK 1.3 billion (US$155 million) to the COVAX distribution mechanism, sponsoring the purchase of 25 million vaccine doses which will be distributed to low-income countries. 

Press release – The Norwegian Ministry of Foreign Affairs